Dermata TherapeuticsDRMA
13F holders, Q2 2026 (June 30)13holders +6
7new positions
1sold out
$1.29avg. 13F price*
At the end of Q2 2026, 13 institutions reported holding Dermata Therapeutics Inc. (DRMA) in their 13F filings, up 6 from Q1 2026. 7 opened new positions and 1 sold out. The largest holders were Geode Capital Management, LLC ($26K), Welch & Forbes LLC ($26K) and State Street Corp. ($24K).
- Company
- Dermata Therapeutics Inc.
- CUSIP
- 249845504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $77K |
| Exits | 1 | $1 |
All 13F filers, Q1 2026 → Q2 2026: 62,965 shares bought and 46,944 shares sold, net +16,021 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Geode Capital Management, LLC | 0.00% | Reduce -58.2% | 20,203 | $26K |
| Welch & Forbes LLC | 0.00% | No change | 20,000 | $26K |
| State Street Corp. | 0.00% | New | 18,747 | $24K |
| UBS Group AG | 0.00% | Reduce -52.8% | 16,796 | $22K |
| Susquehanna International Group, LLP | 0.00% | New | 15,989 | $21K |
| XTX Topco Ltd | 0.00% | New | 14,787 | $19K |
| Advisory Alpha, LLC | 0.00% | New | 10,000 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +439.1% | 3,860 | $5K |
| MCF Advisors LLC | 0.00% | No change | 1,732 | $2K |
| Barclays PLC | 0.00% | New | 270 | $348 |
| SBI Securities Co., Ltd. | 0.00% | No change | 101 | $130 |
| Highline Wealth Partners LLC | 0.00% | New | 26 | $34 |
| Morgan Stanley | 0.00% | New | 2 | $3 |
"% of holder's portfolio" is DRMA's weight in each manager's 13F, not the share of Dermata Therapeutics Inc. the manager owns.